[ad_1] The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what...
[ad_1] First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher”...
[ad_1] The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the...
[ad_1] Investors cheered when a report last week showed the economy expanded in the third quarter after back-to-back contractions. But it’s too early to get excited,...
[ad_1] Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3,...
[ad_1] The omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the week through Oct. 29, accounting for 27.1% of new cases...
[ad_1] The omicron sublineages named BQ.1 and XBB do not appear to have immune escape mutations that warrant being designated as variants of concern, a World...
[ad_1] Almost three years since the start of the coronavirus pandemic and the Chinese city of Wuhan is again in partial lockdown, as it sticks with...
[ad_1] President Joe Biden will receive his updated COVID booster on Tuesday and will urge Americans to get the shot, which targets both the original virus...
[ad_1] The Centers for Disease Control and Prevention is considering using the oral polio vaccine for the first time in more than 20 years to stop...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...
[ad_1] A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine. Mayela Lopez | Reuters The Centers for Disease Control and Prevention...
[ad_1] The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S.,...
[ad_1] The U.S. faces at least seven different versions of Covid-19 omicron as the nation heads into winter when health officials are expecting another wave of...
[ad_1] A new study has found that the COVID antiviral Paxlovid can interact badly with certain heart medications, raising concerns for patients with cardiovascular risk who...
[ad_1] Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated...
[ad_1] Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck...
[ad_1] People who stay up to date on their vaccines and receive treatments when they have breakthrough infections face almost no risk of dying from Covid-19,...
[ad_1] Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according...